Scrip is part of the Informa Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Mitsubishi Tanabe Pharma Generic Subsidiary Launches Six New Drugs

This article was originally published in PharmAsia News

Executive Summary

Mitsubishi Tanabe Pharma subsidiary Tanabe Seiyaku Hanbai launched six new generic drugs in Japan: H2 blocker cimetidine 400mg; angiotensin converting enzyme inhibitor temocapril 1mg, 2mg, 4mg; hypertension drug doxazosin 0.5mg, 1mg, 2mg and 4mg; gastric drug sofalcone 20 percent granule; cefinidir capsule 50 mg, 100mg; antibacterial levafloxacin 100 and 10 percent granule. (Click here for more - Japanese language



Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts